Antibody Production Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the antibody production market looks promising with opportunities in pharmaceutical & biotechnology companies and research laboratories. The global antibody production market is expected to grow with a CAGR of 12%-15% from 2020 to 2025. The major drivers for this market are rise in adoption of targeted immunotherapy and increasing R&D activities in the biopharmaceutical & biotechnology industries for the production of antibody therapeutics.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global antibody production market report, please download the report brochure.
In this market, monoclonal antibody is the largest type of antibody production, whereas pharmaceutical and biotechnology companies is the largest end use. Growth in various segments of the antibody production market are given below:
The study includes trends and forecast for the global antibody production market by type, process, end use, and region as follows:
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that monoclonal antibody will remain the largest type segment over the forecast period due to increasing investment in monoclonal antibody research and a large number of antibody-based product launches.
Within this market, pharmaceutical and biotechnology companies will remain the largest end use segment over the forecast period due to the increasing demand of antibodies in various applications of the pharmaceutical and biotechnology production process.
North America will remain the largest region over the forecast period due to a large number of pharmaceutical and biotechnology companies in the region, the presence of a well-established healthcare market, and growth in the pharmaceutical industry.
Features of the Global Antibody Production Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global antibody production market by type (polyclonal antibody, monoclonal antibody, murine, chimeric, and humanized), process ((upstream processing (bioreactors, consumables, media, buffers and reagents), downstream processing (chromatography systems, chromatography resins), and filtration (filtration systems and filtration consumables & accessories), end use (pharmaceutical and biotechnology companies, research laboratories, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global antibody production market?
Q.5 What are the business risks and threats to the global antibody production market?
Q.6 What are the emerging trends in this antibody production market and the reasons behind them?
Q.7 What are some changing demands of customers in this antibody production market?
Q.8 What are the new developments in this antibody production market? Which companies are leading these developments?
Q.9 Who are the major players in this antibody production market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this antibody production market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global antibody production market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Type (Polyclonal Antibody, Monoclonal Antibody, Murine, Chimeric, and Humanized), Process ((Upstream processing (Bioreactors, Consumables, Media, Buffers and Reagents), Downstream processing (Chromatography Systems, Chromatography Resins), and Filtration (Filtration Systems and Filtration Consumables & Accessories), and End Use (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the antibody production market looks promising with opportunities in pharmaceutical & biotechnology companies and research laboratories. The global antibody production market is expected to grow with a CAGR of 12%-15% from 2020 to 2025. The major drivers for this market are rise in adoption of targeted immunotherapy and increasing R&D activities in the biopharmaceutical & biotechnology industries for the production of antibody therapeutics.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global antibody production market report, please download the report brochure.
In this market, monoclonal antibody is the largest type of antibody production, whereas pharmaceutical and biotechnology companies is the largest end use. Growth in various segments of the antibody production market are given below:
The study includes trends and forecast for the global antibody production market by type, process, end use, and region as follows:
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- Polyclonal Antibody
- Monoclonal Antibody
- Murine
- Chimeric
- Humanized
- Upstream Processing
- Bioreactors
- Consumables
- Media
- Buffers and Reagents
- Downstream Processing
- Chromatography Systems
- Chromatography Resins
- Filtration
- Filtration Systems
- Filtration Consumables and Accessories
- Pharmaceutical and Biotechnology Companies
- Research Laboratories
- Others
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Spain
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Lucintel forecasts that monoclonal antibody will remain the largest type segment over the forecast period due to increasing investment in monoclonal antibody research and a large number of antibody-based product launches.
Within this market, pharmaceutical and biotechnology companies will remain the largest end use segment over the forecast period due to the increasing demand of antibodies in various applications of the pharmaceutical and biotechnology production process.
North America will remain the largest region over the forecast period due to a large number of pharmaceutical and biotechnology companies in the region, the presence of a well-established healthcare market, and growth in the pharmaceutical industry.
Features of the Global Antibody Production Market
- Market Size Estimates: Global antibody production market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global antibody production market size by various segments, such as type, process, and end use in terms of value.
- Regional Analysis: Global antibody production market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different type, process, end use, and region for the global antibody production market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global antibody production market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global antibody production market by type (polyclonal antibody, monoclonal antibody, murine, chimeric, and humanized), process ((upstream processing (bioreactors, consumables, media, buffers and reagents), downstream processing (chromatography systems, chromatography resins), and filtration (filtration systems and filtration consumables & accessories), end use (pharmaceutical and biotechnology companies, research laboratories, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global antibody production market?
Q.5 What are the business risks and threats to the global antibody production market?
Q.6 What are the emerging trends in this antibody production market and the reasons behind them?
Q.7 What are some changing demands of customers in this antibody production market?
Q.8 What are the new developments in this antibody production market? Which companies are leading these developments?
Q.9 Who are the major players in this antibody production market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this antibody production market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global antibody production market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Type (Polyclonal Antibody, Monoclonal Antibody, Murine, Chimeric, and Humanized), Process ((Upstream processing (Bioreactors, Consumables, Media, Buffers and Reagents), Downstream processing (Chromatography Systems, Chromatography Resins), and Filtration (Filtration Systems and Filtration Consumables & Accessories), and End Use (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Antibody Production Market Trends and Forecast
3.3: Global Antibody Production Market by Type
3.3.1: Polyclonal Antibody
3.3.2: Monoclonal Antibody
3.3.3: Murine
3.3.4: Chimeric
3.3.5: Humanized
3.4: Global Antibody Production Market by Process
3.4.1: Upstream Processing
3.4.1.1: Bioreactors
3.4.1.2: Consumables
3.4.1.3: Media
3.4.1.4: Buffers and Reagents
3.4.2: Downstream Processing
3.4.2.1: Chromatography Systems
3.4.2.2: Chromatography Resins
3.4.3: Filtration
3.4.3.1: Filtration Systems
3.4.3.1: Filtration Consumables and Accessories
3.5: Global Antibody Production Market by End Use
3.5.1: Pharmaceutical and Biotechnology Companies
3.5.2: Research Laboratories
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Antibody Production Market by Region
4.2: North American Antibody Production Market
4.2.1: Market by Type: Polyclonal Antibody, Monoclonal Antibody, Murine, Chimeric, and Humanized
4.2.2: Market by Process: Upstream processing (Bioreactors, Consumables, Media, Buffers and Reagents), Downstream processing (Chromatography Systems, Chromatography Resins), and Filtration (Filtration Systems and Filtration Consumables & Accessories
4.2.3: Market by End Use: Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others
4.2.4: The United States Antibody Production Market
4.2.5: The Canadian Antibody Production Market
4.2.6: The Mexican Antibody Production Market
4.3: European Antibody Production Market
4.3.1: Market by Type: Polyclonal Antibody, Monoclonal Antibody, Murine, Chimeric, and Humanized
4.3.2: Market by Process: Upstream processing (Bioreactors, Consumables, Media, Buffers and Reagents), Downstream processing (Chromatography Systems, Chromatography Resins), and Filtration (Filtration Systems and Filtration Consumables & Accessories
4.3.3: Market by End Use: Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others
4.3.4: The United Kingdom Antibody Production Market
4.3.5: The Spanish Antibody Production Market
4.3.6: The German Antibody Production Market
4.3.7: The French Antibody Production Market
4.4: APAC Antibody Production Market
4.4.1: Market by Type: Polyclonal Antibody, Monoclonal Antibody, Murine, Chimeric, and Humanized
4.4.2: Market by Process: Upstream processing (Bioreactors, Consumables, Media, Buffers and Reagents), Downstream processing (Chromatography Systems, Chromatography Resins), and Filtration (Filtration Systems and Filtration Consumables & Accessories
4.4.3: Market by End Use: Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others
4.4.4: The Chinese Antibody Production Market
4.4.5: The Indian Antibody Production Market
4.4.6: The Japanese Antibody Production Market
4.5: ROW Antibody Production Market
4.5.1: Market by Type: Polyclonal Antibody, Monoclonal Antibody, Murine, Chimeric, and Humanized
4.5.2: Market by Process: Upstream processing (Bioreactors, Consumables, Media, Buffers and Reagents), Downstream processing (Chromatography Systems, Chromatography Resins), and Filtration (Filtration Systems and Filtration Consumables & Accessories
4.5.3: Market by End Use: Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others
4.5.4: Brazilian Antibody Production Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Antibody Production Market by Product
7.1.2: Growth Opportunities for the Global Antibody Production Market by Process
7.1.3: Growth Opportunities for the Global Antibody Production Market by End Use
7.1.4: Growth Opportunities for the Global Antibody Production Market by Region
7.2: Emerging Trends in the Global Antibody Production Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Antibody Production Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Antibody Production Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Merck KGaA
8.2: Therm Fisher Scientific, Inc.
8.3: Pall Corporation
8.4: Sartorius
8.5: GE Healthcare
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Antibody Production Market Trends and Forecast
3.3: Global Antibody Production Market by Type
3.3.1: Polyclonal Antibody
3.3.2: Monoclonal Antibody
3.3.3: Murine
3.3.4: Chimeric
3.3.5: Humanized
3.4: Global Antibody Production Market by Process
3.4.1: Upstream Processing
3.4.1.1: Bioreactors
3.4.1.2: Consumables
3.4.1.3: Media
3.4.1.4: Buffers and Reagents
3.4.2: Downstream Processing
3.4.2.1: Chromatography Systems
3.4.2.2: Chromatography Resins
3.4.3: Filtration
3.4.3.1: Filtration Systems
3.4.3.1: Filtration Consumables and Accessories
3.5: Global Antibody Production Market by End Use
3.5.1: Pharmaceutical and Biotechnology Companies
3.5.2: Research Laboratories
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Antibody Production Market by Region
4.2: North American Antibody Production Market
4.2.1: Market by Type: Polyclonal Antibody, Monoclonal Antibody, Murine, Chimeric, and Humanized
4.2.2: Market by Process: Upstream processing (Bioreactors, Consumables, Media, Buffers and Reagents), Downstream processing (Chromatography Systems, Chromatography Resins), and Filtration (Filtration Systems and Filtration Consumables & Accessories
4.2.3: Market by End Use: Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others
4.2.4: The United States Antibody Production Market
4.2.5: The Canadian Antibody Production Market
4.2.6: The Mexican Antibody Production Market
4.3: European Antibody Production Market
4.3.1: Market by Type: Polyclonal Antibody, Monoclonal Antibody, Murine, Chimeric, and Humanized
4.3.2: Market by Process: Upstream processing (Bioreactors, Consumables, Media, Buffers and Reagents), Downstream processing (Chromatography Systems, Chromatography Resins), and Filtration (Filtration Systems and Filtration Consumables & Accessories
4.3.3: Market by End Use: Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others
4.3.4: The United Kingdom Antibody Production Market
4.3.5: The Spanish Antibody Production Market
4.3.6: The German Antibody Production Market
4.3.7: The French Antibody Production Market
4.4: APAC Antibody Production Market
4.4.1: Market by Type: Polyclonal Antibody, Monoclonal Antibody, Murine, Chimeric, and Humanized
4.4.2: Market by Process: Upstream processing (Bioreactors, Consumables, Media, Buffers and Reagents), Downstream processing (Chromatography Systems, Chromatography Resins), and Filtration (Filtration Systems and Filtration Consumables & Accessories
4.4.3: Market by End Use: Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others
4.4.4: The Chinese Antibody Production Market
4.4.5: The Indian Antibody Production Market
4.4.6: The Japanese Antibody Production Market
4.5: ROW Antibody Production Market
4.5.1: Market by Type: Polyclonal Antibody, Monoclonal Antibody, Murine, Chimeric, and Humanized
4.5.2: Market by Process: Upstream processing (Bioreactors, Consumables, Media, Buffers and Reagents), Downstream processing (Chromatography Systems, Chromatography Resins), and Filtration (Filtration Systems and Filtration Consumables & Accessories
4.5.3: Market by End Use: Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others
4.5.4: Brazilian Antibody Production Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Antibody Production Market by Product
7.1.2: Growth Opportunities for the Global Antibody Production Market by Process
7.1.3: Growth Opportunities for the Global Antibody Production Market by End Use
7.1.4: Growth Opportunities for the Global Antibody Production Market by Region
7.2: Emerging Trends in the Global Antibody Production Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Antibody Production Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Antibody Production Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Merck KGaA
8.2: Therm Fisher Scientific, Inc.
8.3: Pall Corporation
8.4: Sartorius
8.5: GE Healthcare
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
